HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew Ku Selected Research

Otitis Media

11/2020An extended release ciprofloxacin/dexamethasone hydrogel for otitis media.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew Ku Research Topics

Disease

7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 01/2021
5Neoplasms (Cancer)
01/2022 - 01/2020
4Lymphoma (Lymphomas)
01/2021 - 01/2017
2Hematologic Neoplasms (Hematological Malignancy)
10/2022 - 03/2015
2COVID-19
01/2021 - 01/2020
1Hypoalbuminemia
10/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022
1Chemotherapy-Related Cognitive Impairment
10/2021
1Infections
01/2021
1Hodgkin Disease (Hodgkin's Disease)
12/2020
1Pathologic Complete Response
12/2020
1Otitis Media
11/2020
1Splenomegaly
01/2019
1Polycythemia (Erythrocytosis)
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2017
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2014
1Pure Red-Cell Aplasia
03/2014
1Autism Spectrum Disorder
01/2014
1Neurodevelopmental Disorders
01/2014
1Myocardial Infarction
01/2011
1Aortic Dissection
01/2011

Drug/Important Bio-Agent (IBA)

5selinexorIBA
02/2022 - 01/2021
3Methotrexate (Mexate)FDA LinkGeneric
10/2022 - 01/2020
2Drug CombinationsIBA
11/2020 - 01/2017
1tafasitamabIBA
01/2022
1Lenalidomide (CC 5013)FDA Link
01/2022
1Alkylating AgentsIBA
01/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021
1COVID-19 VaccinesIBA
01/2021
1Ciprofloxacin (Cipro)FDA LinkGeneric
11/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2020
1HydrogelsIBA
11/2020
1Protein Tyrosine PhosphatasesIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Surface Antigens (Surface Antigen)IBA
01/2017
1Bispecific AntibodiesIBA
01/2017
1Rituximab (Mabthera)FDA Link
01/2017
1src-Family KinasesIBA
03/2015
1Biomarkers (Surrogate Marker)IBA
01/2014
1LumicanIBA
01/2011
1N 30IBA
01/2011

Therapy/Procedure

11Therapeutics
01/2022 - 03/2015
2Stem Cell Transplantation
10/2021 - 01/2021
2Drug Therapy (Chemotherapy)
12/2020 - 03/2014
1Activities of Daily Living (ADL)
10/2021
1Cognitive Training
10/2021
1Radiotherapy
01/2021
1Middle Ear Ventilation (Tympanostomy)
11/2020